Personalized medicine approach in mycobacterial disease

International Journal of Mycobacteriology

Volumn 1, Issue 2, 2012, Pages 59-64

  Mirsaeidi, Mehdi ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Mycobacterial; NTM; Personalized medicine; TB

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; HLA ANTIGEN; INTERLEUKIN 12 RECEPTOR BETA1; MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR 2; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR;

ANTIBIOTIC THERAPY; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; LIVER TOXICITY; MYCOBACTERIOSIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84887213643     PISSN: 22125531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2012.03.001     Document Type: Review

References (42)

1. Global tuberculosis control: WHO report. Accessible in , 2011. http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf.
2. Cook J.L. Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts. British Medical Bulletin 2010, 96:45-59.
3. Tabarsi P., Baghaei P., Farnia P., Mansouri N., Chitsaz E., Sheikholeslam F., et al. Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria. The American Journal of the Medical Sciences 2009, 337(3):182-184.
4. Winthrop K.L., McNelley E., Kendall B., Marshall-Olson A., Morris C., Cassidy M., et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. American Journal of Respiratory and Critical Care Medicine 2010, 182(7):977-982.
5. Adjemian J., Olivier K., Seitz A.E., Holland S.M., Prevots D.R. Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. American Journal of Respiratory and Critical Care Medicine 2012.
6. van Beers S.M., de Wit M.Y., Klatser P.R. The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiology Letters 1996, 136(3):221-230.
7. Young B., Squires K., Patel P., Dejesus E., Bellos N., Berger D., et al. First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America. AIDS 2008, 22(13):1673-1675.
8. Chang L.J., Chen S.U., Tsai Y.Y., Hung C.C., Fang M.Y., Su Y.N., et al. An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening. Clinical and Experimental Reproductive Medicine 2011, 38(3):126-134.
9. Laedtke A.L., O'Neill S.M., Rubinstein W.S., Vogel K.J. Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA). Journal of Genetic Counseling 2011.
10. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., Lander E.S. High-resolution haplotype structure in the human genome. Nature Genetics 2001, 29(2):229-232.
11. Patil N., Berno A.J., Hinds D.A., Barrett W.A., Doshi J.M., Hacker C.R., et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001, 294(5547):1719-1723.
12. Balding D.J. A tutorial on statistical methods for population association studies. Nature Reviews. Genetics 2006, 7(10):781-791.
13. Hirschhorn J.N., Daly M.J. Genome-wide association studies for common diseases and complex traits. Nature Reviews. Genetics 2005, 6(2):95-108.
14. Dubos R.J., Dubos J. The White Plague: Tuberculosis, Man and Society 1952, Little, Brown & Co, Boston, (pp. 188-189).
15. Mirsaeidi S.M., Houshmand M., Tabarsi P., Banoei M.M., Zargari L., Amiri M., et al. Lack of association between interferon-gamma receptor-1 polymorphism and pulmonary TB in Iranian population sample. The Journal of Infection 2006, 52(5):374-377.
16. S.M. Mirsaeidi, P. Tabarsi, A. Mardanloo, G. Ebrahimi, M. Amiri, P. Farnia, et al., Pulmonary mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor? Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace/Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 65(2) (2006) 106-109.
17. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine 2007, 175(4):367-416.
18. Moller M., Hoal E.G. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 2010, 90(2):71-83.
19. Koh W.J., Kwon O.J., Kim E.J., Lee K.S., Ki C.S., Kim J.W. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 2005, 128(1):94-101.
20. Ryu Y.J., Kim E.J., Koh W.J., Kim H., Kwon O.J., Chang J.H. Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases. Clinical and Vaccine Immunology: CVI 2006, 13(7):818-819.
21. Park H.Y., Kwon Y.S., Ki C.S., Suh G.Y., Chung M.P., Kim H., et al. Interleukin-12 receptor beta1 polymorphisms and nontuberculous mycobacterial lung diseases. Lung 2008, 186(4):241-245.
22. Hwang J.H., Kim E.J., Koh W.J., Kim S.Y., Lee S.H., Suh G.Y., et al. Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases. Tuberculosis 2007, 87(2):166-171.
23. Mansouri D., Adimi P., Mirsaeidi M., Mansouri N., Khalilzadeh S., Masjedi M.R., et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. European Journal of Pediatrics 2005, 164(12):753-757.
24. Merza M., Farnia P., Anoosheh S., Varahram M., Kazampour M., Pajand O., et al. The NRAMPI, VDR and TNF-alpha gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 2009, 13(4):252-256.
25. Banoei M.M., Mirsaeidi M.S., Houshmand M., Tabarsi P., Ebrahimi G., Zargari L., et al. Vitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian population. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 2010, 14(1):e84-5.
26. Houshmand M., Banoei M.M., Tabarsi P., Panahi M.S., Kashani B.H., Ebrahimi G., et al. Do mitochondrial DNA haplogroups play a role in susceptibility to tuberculosis?. Respirology 2007, 12(6):823-827.
27. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. The Journal of Experimental Medicine 1993, 178(6):2243-2247.
28. Hirsch C.S., Toossi Z., Othieno C., Johnson J.L., Schwander S.K., Robertson S., et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. The Journal of Infectious Diseases 1999, 180(6):2069-2073.
29. Vogt G., Chapgier A., Yang K., Chuzhanova N., Feinberg J., Fieschi C., et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nature Genetics 2005, 37(7):692-700.
30. Awomoyi A.A., Charurat M., Marchant A., Miller E.N., Blackwell J.M., McAdam K.P., et al. Polymorphism in IL1B: IL1B-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1beta in IFN-gamma primed ex-vivo whole blood assay. Journal of Endotoxin Research 2005, 11(5):281-286.
31. Gomez L.M., Camargo J.F., Castiblanco J., Ruiz-Narvaez E.A., Cadena J., Anaya J.M. Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens 2006, 67(4):290-296.
32. Amirzargar A.A., Rezaei N., Jabbari H., Danesh A.A., Khosravi F., Hajabdolbaghi M., et al. Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. European Cytokine Network 2006, 17(2):84-89.
33. Remus N., El Baghdadi J., Fieschi C., Feinberg J., Quintin T., Chentoufi M., et al. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. The Journal of Infectious Diseases 2004, 190(3):580-587.
34. Akahoshi M., Nakashima H., Miyake K., Inoue Y., Shimizu S., Tanaka Y., et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Human Genetics 2003, 112(3):237-243.
35. Singh S.P., Mehra N.K., Dingley H.B., Pande J.N., Vaidya M.C. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. The Journal of Infectious Diseases 1983, 148(4):676-681.
36. Tajik N., Shah-hosseini A., Mohammadi A., Jafari M., Nasiri M., Radjabzadeh M.F., et al. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens 2012, 79(2):90-96.
37. Feng W.X., Flores-Villanueva P.O., Mokrousov I., Wu X.R., Xiao J., Jiao W.W., et al. CCL2-2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis. International Journal of Tuberculosis and Lung Disease 2012, 16(2):150-156.
38. Png E., Alisjahbana B., Sahiratmadja E., Marzuki S., Nelwan R., Balabanova Y., et al. A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians. BMC Medical Genetics 2012, 13(1):5.
39. Garcia-Elorriaga G., Carrillo-Montes G., Mendoza-Aguilar M., Gonzalez-Bonilla C. Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. Inflammation 2010, 33(4):267-275.
40. Roy P.D., Majumder M., Roy B. Pharmacogenomics of anti-TB drugs-related hepatotoxicity. Pharmacogenomics 2008, 9(3):311-321.
41. Ben Mahmoud L., Ghozzi H., Kamoun A., Hakim A., Hachicha H., Hammami S., et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis. Pathologie-Biologie 2011.
42. Wang J., Tang S., Shen H. Association of genetic polymorphisms in the IL12-IFNG pathway with susceptibility to and prognosis of pulmonary tuberculosis in a Chinese population. European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2010, 29(10):1291-1295.